Drug Trial Radar · NCT06490991
Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Dec 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Jul 17, 2024
Primary completion
Aug 6, 2024
Study completion Sep 10, 2024
Sponsor
- Lead sponsor
- Chengdu Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is designed as a single-center, randomized, open-label, cross-over phase I clinical trial with the intention of recruiting 16 healthy subjects.
Conditions
- Paroxysmal Nocturnal Hemoglobinuria,IgA Nephropathy
Interventions
HRS-5965 tablets;HRS-5965 capsulesDrug
Medication regimen: 1 Drug: HRS-5965 tablets Medication regimen: 2 Drug: HRS-5965 capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- The relative bioavailability (Fr) values between HRS-5965 capsules and HRS-5965 tablets taken on an empty stomachTime frame: 0-144hours
- Relative bioavailability (Fr) values of HRS-5965 capsules taken on an empty stomachTime frame: 0-144hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ZhongShan Hospital FuDan University
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.